Study of Efficacy and Safety of Asciminib in Combination With Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
Novartis
Novartis
Pfizer
Novartis
Teva Branded Pharmaceutical Products R&D, Inc.
Ariad Pharmaceuticals
Novartis